Resveratrol Inhibits Rat Aortic Vascular Smooth Muscle Cell Proliferation via Estrogen Receptor Dependent Nitric Oxide Production
Authors:
- Valeria Y HebertVHValeria Y Hebert
- Alok KhandelwalAKAlok Khandelwal
- Tammy R DugasTammy R Dugas
- 1 July 2007
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 50 (1) , 83-93
Abstract
Vascular smooth muscle cell (VSMC) proliferation is pivotal in the progression of hypertension, atherosclerosis, and restenosis. Resveratrol is a grape polyphenol that is implicated as an important contributor to red wine's vascular protective effects. Its antimitogenic action on VSMC is attributed to an array of pleiotropic effects, including modulation of the estrogen receptor (ER). To elucidate the mechanisms underlying resveratrol-mediated ER modulation and its inhibition of VSMC proliferation, we treated VSMC with resveratrol with or without the ER antagonist ICI 182,780 and measured cell proliferation and nitric oxide (NO) production. Resveratrol dose-dependently decreased VSMC DNA synthesis, with a half maximal inhibitory concentration (IC50) of 3.73+/-0.57 microM, and dramatically slowed cell growth, but did not induce VSMC apoptosis. Resveratrol-mediated decrease in proliferation was reversed by cotreatment with ICI 182,780, and resveratrol effectively competed with 17beta-estradiol for binding to the ER, exhibiting an IC50 of 8.92+/-0.14 microM. Resveratrol induced a sustained increase in ER-dependent NO production. Further, resveratrol-mediated decrease in VSMC proliferation was blunted by cotreatment with the general nitric oxide synthase (NOS) inhibitor N5-(1-Iminomethyl)-L-ornithine, dihydrochloride or with the inducible NOS (iNOS)-selective inhibitor S,S'-1,4-phenylene-bis (1,2-ethanediyl)bis-isothiourea, dihydrobromide, but not with the neuronal NOS-selective inhibitor 7-nitroindazole. Though resveratrol did not alter iNOS protein levels, it dose-dependently increased levels of iNOS activity, of the iNOS cofactor tetrahydrobiopterin (BH4), and of guanosine triphosphate cyclohydrolase I protein, the rate-limiting enzyme in BH4 biosynthesis. In addition, all of these effects were abolished by cotreatment with ICI 182,780. Thus, the antimitogenic effects of resveratrol on VSMC may be mediated by an ER-induced increase in iNOS activity.Keywords
This publication has 55 references indexed in Scilit:
- Statins Effect on Smooth Muscle Cell ProliferationSeminars in Vascular Medicine, 2004
- Antiproliferative Strategies for the Treatment of Vascular Proliferative DiseaseCurrent Vascular Pharmacology, 2003
- Effects of Homocysteine on Proliferation, Necrosis, and Apoptosis of Vascular Smooth Muscle Cells in Culture and Influence of Folic AcidThrombosis Research, 2001
- Effect of resveratrol on intimal hyperplasia after endothelial denudation in an experimental rabbit modelLife Sciences, 2000
- Resveratrol content in wines and musts from the south of SpainMolecular Nutrition & Food Research, 2000
- Resveratrol Inhibits AGEs-Induced Proliferation and Collagen Synthesis Activity in Vascular Smooth Muscle Cells from Stroke-Prone Spontaneously Hypertensive RatsBiochemical and Biophysical Research Communications, 2000
- Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin‐1 stimulatory effectsFEBS Letters, 1999
- Responses of vascular smooth muscle cells to toxic insult: Cellular and molecular perspectives for environmental toxicantsJournal of Toxicology and Environmental Health, 1994
- Differential effects of alcoholic beverages on experimental atherosclerosis in rabbitsExperimental and Molecular Pathology, 1981
- CORONARY HEART DISEASE IN MIDDLE-AGED FRENCHMENThe Lancet, 1980